Prognostic significance of copy-number alterations in multiple myeloma - Wikidata - thesis-toulmin - TriplyDB

Prognostic significance of copy-number alterations in multiple myeloma

Prognostic significance of copy-number alterations in multiple myeloma

http://www.wikidata.org/entity/Q24643402

about

Molecular pathogenesis of multiple myeloma: basic and clinical updates Clonal evolution in hematological malignancies and therapeutic implications Impact of high-risk classification by FISH: an eastern cooperative oncology group (ECOG) study E4A03.Laminin-binding integrin gene copy number alterations in distinct epithelial-type cancers Combining fluorescent in situ hybridization data with ISS staging improves risk assessment in myeloma: an International Myeloma Working Group collaborative project.Sample size considerations of prediction-validation methods in high-dimensional data for survival outcomes.How I treat plasma cell leukemia.International staging system and metaphase cytogenetic abnormalities in the era of gene expression profiling data in multiple myeloma treated with total therapy 2 and 3 protocols Genome-wide screening of cytogenetic abnormalities in multiple myeloma patients using array-CGH technique: a Czech multicenter experience.The dChip survival analysis module for microarray data.New strategies in the treatment of multiple myeloma.Total Therapy 3 for multiple myeloma: prognostic implications of cumulative dosing and premature discontinuation of VTD maintenance components, bortezomib, thalidomide, and dexamethasone, relevant to all phases of therapy Minor clone provides a reservoir for relapse in multiple myeloma Gene expression profile alone is inadequate in predicting complete response in multiple myeloma.Classify hyperdiploidy status of multiple myeloma patients using gene expression profiles Dilemmas in treating smoldering multiple myeloma.The shaping and functional consequences of the dosage effect landscape in multiple myeloma.Pathway-based identification of SNPs predictive of survival Chromothripsis identifies a rare and aggressive entity among newly diagnosed multiple myeloma patients.Genetics of multiple myeloma: another heterogeneity level?Role of additional chromosomal changes in the prognostic value of t(4;14) and del(17p) in multiple myeloma: the IFM experience Pathogenesis beyond the cancer clone(s) in multiple myeloma.Heterogeneous chromosome 12p deletion is an independent adverse prognostic factor and resistant to bortezomib-based therapy in multiple myeloma.Genes with a spike expression are clustered in chromosome (sub)bands and spike (sub)bands have a powerful prognostic value in patients with multiple myeloma Molecular pathogenesis of multiple myeloma and its premalignant precursor.Understanding the role of hyperdiploidy in myeloma prognosis: which trisomies really matter?Multiple Myeloma: Treatment is Getting Individualized Detection of recurrent cytogenetic aberrations in multiple myeloma: a comparison between MLPA and iFISH.The 39th David A. Karnofsky Lecture: bench-to-bedside translation of targeted therapies in multiple myeloma.Uncovering the biology of multiple myeloma among African Americans: a comprehensive genomics approach Thalidomide in total therapy 2 overcomes inferior prognosis of myeloma with low expression of the glucocorticoid receptor gene NR3C1 Chromosomal abnormalities are major prognostic factors in elderly patients with multiple myeloma: the intergroupe francophone du myélome experience.Treatment of multiple myeloma with high-risk cytogenetics: a consensus of the International Myeloma Working Group.Genomics in multiple myeloma.A DNA target-enrichment approach to detect mutations, copy number changes and immunoglobulin translocations in multiple myeloma.Genomic profiling of plasma cell disorders in a clinical setting: integration of microarray and FISH, after CD138 selection of bone marrow.Chromosome 1q21 gains confer inferior outcomes in multiple myeloma treated with bortezomib but copy number variation and percentage of plasma cells involved have no additional prognostic value.Observation on frequency & clinico-pathological significance of various cytogenetic risk groups in multiple myeloma: an experience from India.Jumping translocations of 1q12 in multiple myeloma: a novel mechanism for deletion of 17p in cytogenetically defined high-risk disease.The genetic architecture of multiple myeloma.

P2860

Q27026205-429AFF61-F2D6-4C69-AFDA-BDC5D1C53516 Q27027655-8C5FA548-26BC-4FF6-A523-D940E1E0CEAF Q30424188-25DF68EE-7DAE-4376-98D1-8EF0220FAD1D Q30489312-2ED2F0EB-BCC7-44A8-81F0-CCD62DDD812A Q30571858-24E456FC-79D9-4631-99E3-A8B9B3BCF174 Q30597109-3E4DBF8D-4865-4BB2-9995-951D0F70425D Q33402555-4AF9CFB5-054B-4BDB-8B22-B733050E7994 Q33718273-A239404A-0BC7-4F83-8EE8-72BCED226D57 Q33768000-671EE777-56F8-4838-A38A-E4D99DA731C3 Q33841474-52D00462-A2D5-475C-957B-BEC0D135FDD3 Q33958520-CCE65C15-C529-4996-9780-EEDA412A47EF Q34122646-0C2CA7B1-1140-46A0-8D74-52ABBA302FD6 Q34147170-F604B3C6-CCD0-46E6-AB26-9A08E8365294 Q34345502-CAB1BAC4-3581-49A3-8CE4-A8F8F497066B Q34648345-5EE21F59-F7AB-4214-BF98-9643E6F6EBD4 Q34716500-4D924E72-D6CC-497D-B515-8FBFEA0A1B27 Q35006859-308528E4-9367-4089-AADB-C6A51DF22AB6 Q35031013-C7F8927E-F76F-4319-8D00-FE833C024A36 Q35125918-CAA737EC-E51D-4639-BE7E-12049F0E7013 Q35197437-18867A6B-7CAC-4FCA-8575-1D4203352990 Q35220653-1DEA87E8-8B24-4EF7-BCA8-96A964A8914A Q35607266-609060E5-DE12-4353-9E25-C793071E1ADD Q35832389-852CE127-2E7A-46D9-812F-C338519FD9B9 Q35944699-FEF0CFF9-5D2A-49DA-B796-FA0071CA867A Q36290238-27403728-29FE-47B0-BEAD-3F0C23D9C2CE Q36382187-8DE1E8FF-5072-4AF7-A8A1-037AA9A2BA53 Q36522964-2A2EEFF5-1366-41F8-83C6-5212D8CB9FA1 Q36544069-3567783B-3D9E-464B-9CA3-E6000DDF8D02 Q36709283-152103B3-6AB7-4101-A8AA-5D40AF5A6ADF Q36779423-0A20F677-E6AF-456A-9B42-9A0FECF63C37 Q36915777-E58E58AF-1FBA-4E60-A6CD-2A4FB9E782E6 Q37033951-75D92DB6-5974-4A34-9B73-B76C94E882E2 Q37037265-FA8839F0-E15E-405D-831A-167619D75355 Q37197359-0A5444E9-6424-430A-9898-8AEEEEFC4514 Q37325007-517847B4-AA1E-4496-A080-32CB035ABD22 Q37465362-33F1E37A-80C6-4871-940E-C6D4B8BD2DE0 Q37552056-46EB85F0-E02B-4833-9AB2-3408937371FC Q37692687-356218A5-A66A-4FAC-B5FB-D22FDDCD12A7 Q37709342-F7E825EE-2A5C-43D5-92DB-A4A5C0447EB3 Q37718836-1364F60F-C10E-4B3D-A00C-2DCEF62208B2

P2860

Prognostic significance of copy-number alterations in multiple myeloma

http://www.wikidata.org/entity/Q24643402

description

2009 nî lūn-bûn

@nan

2009 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Prognostic significance of copy-number alterations in multiple myeloma

@ast

Prognostic significance of copy-number alterations in multiple myeloma

@en

Prognostic significance of copy-number alterations in multiple myeloma

@nl

type

label

Prognostic significance of copy-number alterations in multiple myeloma

@ast

Prognostic significance of copy-number alterations in multiple myeloma

@en

Prognostic significance of copy-number alterations in multiple myeloma

@nl

prefLabel

Prognostic significance of copy-number alterations in multiple myeloma

@ast

Prognostic significance of copy-number alterations in multiple myeloma

@en

Prognostic significance of copy-number alterations in multiple myeloma

@nl

P1433

Q24643402-8157EE43-6F68-4E95-88B7-159C2C25D2CF

P1476

Q24643402-ECFDD8FB-C765-471A-91C8-F6F05E9DE6DB

P2093

Q24643402-0603D41F-DB03-4B3D-96A8-B7BA3DDFFA47

Q24643402-08A52F5C-3057-469A-9564-77AE72368B58

Q24643402-1DC83D06-32DA-494A-A3AD-C1915BBB438C

Q24643402-20BD80A7-E1FF-4A52-90D4-D600DD011C3B

Q24643402-510B2B56-CBA4-49FB-8F26-E5A547488662

Q24643402-AA057C95-F000-4093-AC0A-BD1F93D09553

Q24643402-CDD95D2A-0B89-4593-BD52-B82E5A68B89F

Q24643402-DBDA326B-76A4-4DCB-9A9C-508E3FFB244A

Q24643402-E9D1BEA4-652D-415E-A571-9A676C1D5612

P2860

Q24643402-0C985770-3407-4D69-B790-7B774621706E

Q24643402-21982077-5A30-4244-89E8-213A5BEC0A48

Q24643402-30783BC1-3BBF-4230-9058-263AC682D7AA

Q24643402-30A99BE9-5F74-4D25-8D9E-952FB122032C

Q24643402-3A42D28E-9350-4700-B611-5830EFBFFD73

Q24643402-40BDC4C4-3E54-4FC1-B12B-6D7C2665979F

Q24643402-4AB769BF-881F-4FC7-A929-8BE07B8D5840

Q24643402-4D0BF800-97B0-4E03-8B01-F374BC6E1535

Q24643402-5086DF92-92A5-4441-B744-C85007075168

Q24643402-52E9C96E-B1F9-48A2-B982-750CAA70B523

P304

Q24643402-690A227E-6250-4703-8653-0A6DE6A2C95E

P31

Q24643402-5105E4D9-4980-4747-93B2-05B88F61E13E

P3181

Q24643402-7CA8CA6D-293A-48DF-99EE-6D6C691962B8

P356

Q24643402-C9A715C1-EBDB-4F03-86F8-3FE2375DADE4

P407

Q24643402-9818F836-3CAC-4E26-AF26-C74B94FBFAB0

P433

Q24643402-AECC5DBA-0B6A-42CB-B374-F38688B98217

P478

Q24643402-B9BD4CA6-F8FB-4B57-876B-8939F76F256D

P50

Q24643402-20A3ECEB-BA8B-4066-BBAF-4117A9C567F7

Q24643402-27AC4BCD-298A-4559-B66B-778C79D0A2E8

Q24643402-6B1FB15E-F583-485B-A83A-7FDC4278DDF6

Q24643402-6E202CA0-969C-450F-A55C-C69373B57DFF

Q24643402-DD3E464A-1FF3-4DBA-8377-20EC708BD478

Q24643402-DF5215B6-6367-47E7-9BEA-11225B0B8873

P577

Q24643402-391FF5C6-33C8-41B6-9F2F-1A336049617B

P5875

Q24643402-25FD24BB-74FD-482F-89B3-3EE270ACFBBA

P698

Q24643402-675C63C4-7F25-4897-8ADB-2923B1681759

P932

Q24643402-10D1BB5B-4C82-4A0E-9B6A-ACEED911336F

P3181

P356

JCO.2008.20.6136

P1433

Journal of Clinical Oncology

P1476

Prognostic significance of copy-number alterations in multiple myeloma

@en

P2093

Catherine Charbonnel

http://www.w3.org/2001/XMLSchema#string

Cheng Li

http://www.w3.org/2001/XMLSchema#string

Claire Mathiot

http://www.w3.org/2001/XMLSchema#string

Gerald Marit

http://www.w3.org/2001/XMLSchema#string

Jean-Luc Harousseau

http://www.w3.org/2001/XMLSchema#string

Michel Attal

http://www.w3.org/2001/XMLSchema#string

Nikhil C Munshi

http://www.w3.org/2001/XMLSchema#string

Stéphane Minvielle

http://www.w3.org/2001/XMLSchema#string

Wilfried Gouraud

http://www.w3.org/2001/XMLSchema#string

P2860

Inferring loss-of-heterozygosity from unpaired tumors using high-density oligonucleotide SNP arrays

Expression and regulation by interferon of a double-stranded-RNA-specific adenosine deaminase from human cells: evidence for two forms of the deaminase

ADAR1 interacts with NF90 through double-stranded RNA and regulates NF90-mediated gene expression independently of RNA editing

ADAR1 is essential for the maintenance of hematopoiesis and suppression of interferon signaling

Circular binary segmentation for the analysis of array-based DNA copy number data

dChipSNP: significance curve and clustering of SNP-array-based loss-of-heterozygosity data.

Deletion of 13q14 remains an independent adverse prognostic variable in multiple myeloma despite its frequent detection by interphase fluorescence in situ hybridization.

Global gene expression profiling of multiple myeloma, monoclonal gammopathy of undetermined significance, and normal bone marrow plasma cells.

The molecular classification of multiple myeloma

The differentiation and stress response factor XBP-1 drives multiple myeloma pathogenesis.

P304

4585-90

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

3701546

http://www.w3.org/2001/XMLSchema#string

P356

10.1200/JCO.2008.20.6136

http://www.w3.org/2001/XMLSchema#string

P407

P433

27

http://www.w3.org/2001/XMLSchema#string

P478

27

http://www.w3.org/2001/XMLSchema#string

P50

Hervé Avet-Loiseau

Florence Magrangeas

Kenneth C Anderson

Philippe Moreau

P577

2009-09-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

26748402

http://www.w3.org/2001/XMLSchema#string

P698

19687334

http://www.w3.org/2001/XMLSchema#string

P932

2754906

http://www.w3.org/2001/XMLSchema#string